Anxiety disorders and migraine intractability and progression

Current Pain and Headache Reports

Volumn 12, Issue 3, 2008, Pages 224-229

  Smitherman, Todd A ^a   Penzien, Donald B ^b   Maizels, Morris ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIMIGRAINE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN AGONIST; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; VENLAFAXINE;

ANAMNESIS; ANXIETY DISORDER; AVOIDANCE BEHAVIOR; BEHAVIOR THERAPY; CHRONICITY; COMORBIDITY; COPING BEHAVIOR; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG ABUSE; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; EMOTIONAL STRESS; FEAR; GENERALIZED ANXIETY DISORDER; HEALTH CARE COST; HUMAN; MEDICAL RESEARCH; MEDLINE; MIGRAINE; OBSESSIVE COMPULSIVE DISORDER; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PHYSICAL CAPACITY; POSTTRAUMATIC STRESS DISORDER; PROGNOSIS; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RATING SCALE; REVIEW; RISK FACTOR; SELF REPORT; SLEEP TIME; SOCIAL PHOBIA;

ANIMALS; ANXIETY DISORDERS; DISEASE PROGRESSION; HEADACHE DISORDERS; HUMANS; MIGRAINE DISORDERS; RISK FACTORS;

EID: 48749119053     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-008-0039-9     Document Type: Review

References (51)

1. Lipton RB, Pan J: Is migraine a progressive brain disease? JAMA 2004, 291:493-494.
2. Lipton RB, Bigal MG: Concepts and mechanisms of migraine chronification. Headache 2008, 48:7-15.
3. Scher AI, Midgette LA, Lipton RB: Risk factors for headache chronification. Headache 2008, 48:16-25.
4. Breslau N: Psychiatric comorbidity in migraine. Cephalalgia 1998, 18(Suppl 22):S56-S61.
5. Hamelsky SW, Lipton RB: Psychiatric comorbidity of migraine. Headache 2006, 46:1327-1333.
6. Penzien DB, Peatfield RC, Lipchik GL: Headache in patients with co-morbid psychiatric disease. In The Headaches, edn 3. Edited by Olesen J, Goadsby P, Ramadan N, et al.: Philadelphia: Lippincott, Williams & Wilkins; 2006:1117-1124.
7. Juang KD, Wang SJ, Fuh JL, et al.: Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 2000, 40:818-823.
8. Kessler RC, Berglund P, Demler O, et al.: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:593-602.
9. Smitherman TA, Penzien DB, Maizels M: Headache chronification: screening and behavioral management of comorbid psychiatric disorders. Headache 2008, 48:45-50.
10. Radat F, Swendsen J: Psychiatric comorbidity in migraine: a review. Cephalalgia 2005, 25:165-178.
11. Breslau N, Davis GC: Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults. J Psychiatry Res 1993, 27:211-221.
12. Breslau N, Davis GC, Andreski P: Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991, 37:11-23.
13. Breslau N, Schultz LR, Stewart WF, et al.: Headache types and panic disorders: directionality and specificity. Neurology 2001, 56:350-354.
14. Wang SJ, Juang KD, Fuh JL, Lu SR: Psychiatric comorbidity and suicide risk in adolescents with chronic daily headache. Neurology 2007, 68:1468-1473.
15. Guidetti V, Galli F, Fabrizi P, et al.: Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia 1998, 18:455-462.
16. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4, text revision. Washington, DC: American Psychiatric Association; 2000.
17. de Leeuw R, Schmidt JE, Carlson CR: Traumatic stressors and post-traumatic stress disorder symptoms in headache patients. Headache 2005, 45:1365-1374.
18. Pesa J, Lage, MJ: The medical costs of migraine and comorbid anxiety and depression. Headache 2004, 44:562-570.
19. Stewart WF, Lipton RB, Kolodner K, et al.: Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 1999, 19:107-114.
20. Lantéri-Minet M, Radat F, Chautard MH, Lucas C: Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management. Pain 2005, 118:319-326.
21. Heckman BD, Holroyd KA: Tension-type headache and psychiatric comorbidity. Curr Pain Headache Rep 2006, 10:439-447.
22. Smitherman TA, Penzien DB, Rains JC: Challenges of nonpharmacologic interventions in chronic tension-type headache. Curr Pain Headache Rep 2007, 11:471-477.
23. Ferrari MD, Saxena PR: On serotonin and migraine: a clinical and pharmacological review. Cephalalgia 1993, 13:151-165.
24. Hamel E: Serotonin and migraine: biology and clinical implications. Cephalalgia 2007, 27:1295-3000.
25. Schwedt TJ: Serotonin and migraine: the latest developments. Cephalalgia 2007, 27:1301-1307.
26. Silberstein SD, Freitag FG, Bigal ME: Migraine treatment. In Wolff's Headache and Other Head Pain, edn 8. Edited by Silberstein SD, Lipton RB, Dodick DW. New York: Oxford; 2008:177-292.
27. Lesch KP, Bengel D, Heils A, et al.: Association of anxiety-related traits with a polymorphisms in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
28. Karwautz AFK, Campos de Sousa S, Wöber C, et al.: Family-based analysis of serotonin transporter gene polymorphisms in migraine with and without aura. Cephalalgia 2007, 27:773-780.
29. Dodick D, Freitag F: Evidence-based understanding of medication-overuse headache: clinical implications. Headache 2006, 46(Suppl 4):S202-S211.
30. Mathew NT: Transformed migraine. Cephalalgia 1993, 13(Suppl 12):S78-S83.
31. Mathew NT, Stubits E, Nigam MP: Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982, 22:66-68.
32. Lake AE III: Medication overuse headache: biobehavioral issues and solutions. Headache 2006, 46(Suppl 3):S88-S97.
33. Radat F, Creac'h C, Swendsen JD, et al.: Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 2005, 25:519-522.
34. Radat F, Sakh D, Lutz G, et al.: Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs. Headache 1999, 39:477-480.
35. Asmundson GJG, Norton PJ, Norton GR: Beyond pain: the role of fear and avoidance in chronicity. Clin Psychol Rev 1999, 19:97-119.
36. Nicholson RA, Houle TA, Rhudy JL, Norton, PJ: Psychological risk factors in headache. Headache 2007, 47:413-426.
37. Norton PJ, Asmundson GJG: Anxiety sensitivity, fear, and avoidance behavior in headache pain. Pain 2004, 111:218-223.
38. Barlow DH: Anxiety and Its Disorders, edn 2. New York: Guilford; 2002.
39. Taylor S (ed): Anxiety Sensitivity: Theory, Research, and Treatment of the Fear of Anxiety. Mahwah, NJ: Erlbaum; 1999.
40. Asmundson GJG, Norton PJ, Veloso F: Anxiety sensitivity and fear of pain in patients with recurrent headaches. Behav Res Ther 1999, 37:703-713.
41. Maizels M, Smitherman TA, Penzien DB: A review of screening tools for psychiatric comorbidity in headache patients. Headache 2006, 46(Suppl 3):S98-S109.
42. Kroenke K, Spitzer RL, Williams JBW, et al.: Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007, 146:317-325.
43. Spitzer RL, Kroenke K, Williams JBW, Löwe B: A brief measure for assessing generalized anxiety disorder. Arch Intern Med 2006, 166:1092-1097.
44. Spitzer RL, Kroenke K, Williams JBW, and the Patient Health Questionnaire Primary Care Study Group: Validation and utility of a self-report version of PRIME-MD. JAMA 1999, 282:1737-1744.
45. Tollison CD, Langley JC: P-3: An Overview of the Pain Patient Profile (TM). Minneapolis, MN: National Computer Systems; 1995.
46. Antony MM, Rowa K: Evidence-based assessment of anxiety disorders in adults [review]. Psychol Assess 2005, 17:256-266.
47. Lee ST, Park JH, Kim M: Efficacy of the 5-HT1a agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study. Headache 2005, 45:1004-1011.
48. Griffith JL, Razavi M: Pharmacological management of mood and anxiety disorders in headache patients. Headache 2006, 46(Suppl 3):S133-Sl41.
49. Saper JR, Dodick D, Gladstone JP: Management of chronic daily headache: challenges in clinical practice. Headache 2005, 45(Suppl 1):S74-S85.
50. Rains JC, Penzien DB, Lipchik GL: Behavioral facilitation of medical treatment for headache - part 2: theoretical models and behavioral strategies for improving adherence. Headache 2006, 46:1395-1403.
51. Lipchik GL, Smitherman TA, Penzien DB, Holroyd K: Basic principles and techniques of cognitive-behavioral therapies for comorbid psychiatric symptoms among headache patients. Headache 2006, 46(Suppl 3):S119-S132.